CON insiders

21 insiders have filed at CON since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Ortenzio Robert ADirector8.17M6.357%
Newton William KeithChief Executive Officer482.8k0.376%
Dicanio Matthew T.See Remarks342.3k0.266%
Mcandrew Douglas R.See Remarks114.1k0.089%
Ryan Timothy F.See Remarks114.1k0.089%
Gilbert Greg M.See Remarks114.1k0.089%
Devasia Thomas A.See Remarks114.1k0.089%
Conser Jonathan P.See Remarks114.1k0.089%
Nelson Su ZanSee Remarks114.1k0.089%
Delorimier John A.See Remarks113.6k0.088%
Kosuth Michael A.See Remarks113.6k0.088%
Anderson John Robert JR.See Remarks113.5k0.088%
Gallara GiovanniSee Remarks113.4k0.088%
Rhine Michael D.See Remarks76.2k0.059%
Kendall DanielleSee Remarks76.1k0.059%
Thomas DanielDirector74.0k0.058%
Pegus CherylDirector20.7k0.016%
Watkins Marc R.Director20.7k0.016%
Gopal VipinDirector15.5k0.012%
Bonner Brigid A.Director15.5k0.012%
Select Medical Corp10% owner

Full register at boothcheck.com/insiders/CON. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

CON institutional holders · CON research report